CIMR Neuromuscular Research Biobank
NRB-0001
Center for Inherited Muscle Research Neuromuscular Research Biobank
1 other identifier
observational
500
1 country
1
Brief Summary
The purpose of this research repository is to collect, store, and share with other researchers any tissues that subjects with all types of neuromuscular disease are willing to donate. These samples will be stored at Virginia Commonwealth University (VCU) and will be used for future research with this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 17, 2021
CompletedFirst Submitted
Initial submission to the registry
June 21, 2022
CompletedFirst Posted
Study publicly available on registry
June 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2030
July 4, 2025
July 1, 2025
8.8 years
June 21, 2022
July 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To collect, store, and share with other researchers any tissues that subjects with all types of neuromuscular disease are willing to donate.
Subjects will have the opportunity to provide the following samples: saliva or cheek swab, urine sample (up to 15ml), feces (up to 2mg of a stool sample), blood (up to 40ml), muscle biopsy tissue, and cell line (subjects have the option to allow a cell line to be made from their blood, muscle, or skin biopsies to provide a renewable supply of DNA and other cell components for research)
Baseline
Secondary Outcomes (1)
To collect medical history information from subjects with all types of neuromuscular disease and healthy controls.
Baseline
Eligibility Criteria
This is a very inclusive study that will allow samples from known subjects of sites' neuromuscular clinics, associated family members, and healthy volunteers. This study will include subjects with any form of neuromuscular disorder, including neuromuscular disorders of unknown etiology.
You may qualify if:
- Willing and able to give informed consent
- Positive diagnosis or suspected diagnosis of neuromuscular disease, or
- Family history of neuromuscular disease, or
- Healthy volunteer
- Age Neonates-75
You may not qualify if:
- Unwilling to sign consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
Biospecimen
As part of this repository, subjects will also have the option to allow a cell line to be made from their blood, muscle, or skin biopsies to provide a renewable supply of DNA and other cell components for research. A cell line is a frozen sample of specially processed cells from blood that allows us to grow more cells and obtain more DNA and other cell components, such as RNA or proteins, for future research. The cell line would not be labeled with the subjects name, address, birthdate, or other personal identifiers.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nicholas E. Johnson, MD
Virginia Commonwealth University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2022
First Posted
June 28, 2022
Study Start
March 17, 2021
Primary Completion (Estimated)
January 1, 2030
Study Completion (Estimated)
February 1, 2030
Last Updated
July 4, 2025
Record last verified: 2025-07